Loading…
Endocrine Disruption Prevention Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2010 · fourth_quarter · Telecommunications
Bills with similar content found using semantic analysis.
Sources: Congress.gov
S 921 The United States Information and Communications Enhancement Act of 2009 (US ICE Act of 2009), provisions related to cybersecurity and network reliability and standards S 788 The m-SPAM Act of 2009, all provisions related to network service provider obligations S 649 Radio Spectrum Inventory Act, provisions relating to data collection HR 3125 Radio Spectrum Inventory Act, provisions relating to data collection S 348 Universal Service ADA Exemption, issues related to adding the "internet" as an item for Universal Service support as well as other provisions regarding universl service contributions and the universal service support programs established pursuant to that section are not subject to certain provisions of title 31, US Code, commonly known as the Antideficiency Act HR 2135 issues related to adding the "internet" as an item for Universal Service support as well as other provisions regarding universl service contributions and the universal service support programs established pursuant to that section are not subject to certain provisions of title 31, US Code, commonly known as the Antideficiency Act S 30 Truth in Caller ID Act of 2009, all provisions related to prohibiting manipulation of caller identification information and all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations. HR 1258 Truth in Caller ID Act of 2009, all provisions related to prohibiting manipulation of caller identification information and all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations. HR 760 Advanced Broadband Infrastructure Bond Initiative of 2009, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations HR 400 Protecting Consumers through Proper Forbearance Procedures Act, provisions related to process of FCC forbearance petitions HR 266 Cybersecurity Education Enhancement Act of 2009, provisions relating to network safety, security and reliability HR 2271 Global Online Freedom Act, all provisions related to network service provider obligations HR 2165 Bulk Power System Protection Act of 2009, provisions relating to network safety, security and reliability HR 2221 Data Accountability and Trust Act, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations S 3742 Data Security and Breach Notification Act of 2010, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations HR 1319 Informed P2P User Act, all provisions relating to preventing the inadvertent disclosure of information on a computer through certain "peer-to-peer" file sharing software without first providing notice and obtaining consent from the owner or authorized user of the computer S 3027 P2P Cyber Protection and Informed User Act, all provisions relating to preventing the inadvertent disclosure of information on a computer through certain "peer-to-peer" file sharing software without first providing notice and obtaining consent from the owner or authorized user of the computer S 3480 Protecting Cyberspace as a National Asset Act of 2010, all provisions HR 5548 Protecting Cyberspace as a National Asset Act of 2010, all provisions HR 1133 Family Telephone Connection Protection Act of 2009, all provisions relating to revisions of existing laws, regulation or policy that would impact telecommunications, network or business operations HR 1110 PHONE Act of 2009, all provisions related to preventing Caller ID spoofing, all provisions related to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations HR 1019 State Video Tax Fairness Act of 2009, all provisions related to prohibiting discrimination in State taxation on multichannel video programming distribution services HR 1391 Stop M-Spam Abuse as a Sales Industry Habit Act of 2009, all provisions related to network service provider obligations HR 2537 Same Number Act of 2009, all provisions HR 2428 Broadband Conduit Deployment Act of 2009, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations HR 1266 Broadband Conduit Deployment Act of 2009, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations HR 2449 Wireless Prepaid Access Device Enforcement Act of 2009, all provisions S 920 Information Technology (IT) Investment Oversight Enhancement and Waste Prevention Act of 2009, provisions related to IT procurement HR 3458 Internet Freedom Preservation Act of 2009, issues relating to potential regulation of internet networks S 1447 Connecting America Act of 2009, provisions relating to broadband service providers HR 3646 Broadband Affordability Act, provisions relating to the Universal Service Fund HR 3627 Rural and Small Town Telework Tax Credit Act of 2009, all provisions relating to revisions of existing law, regulation or policies that would impact telecommunications, network or business operations S 946 The Critical Electric Infrastructure Protection Act, provisions concerning IP network services HR 3019 Spectrum Relocation Improvement Act of 2009, all provisions S 3490 Spectrum Relocation Improvement Act of 2010, all provisions HR 3993 Calling Card Consumer Protection Act, provisions relating to consumer disclosure requirements S 562 Prepaid Calling Card Consumer Protection Act of 2009, provisions relating to consumer disclosure requirements S 1938 Distracted Driving Prevention Act of 2009, all provisions HR 3994 Distracted Driving Prevention Act of 2009, all provisions HR 3829 Fighting Occupied Cell Use So Everyone Drives More Safely Act of 2009, all provisions S 1536 ALERT Drivers Act [Avoiding Life-Endangering and Reckless Texting by Drivers Act of 2009], provisions relating to wireless telecommunications providers HR 3535 ALERT Drivers Act [Avoiding Life-Endangering and Reckless Texting by Drivers Act of 2009], provisions relating to wireless telecommunications providers HR 4153 To establish national standards to prevent distracted driving, all provisions HR 5097 Erica's Law, provisions relating to wireless telecommunications providers HR 3745 Community Access Preservation (CAP) Act of 2009, provisions relating to program delivery S 2828 Cell Phone ETF Act, all provisions HR 5583 Cell Phone ETF Act, all provisions S 2879 The Broadband Opportunity and Affordability Act (BOAA), provisions relating to Universal Service Fund HR 4619 E -Rate 2.0, provisions relating to broadband service providers HR 4545 Rural Broadband Initiative Act of 2010, provisions relating to obligations of broadband service providers S 2880 Rural Broadband Initiative Act of 2010, provisions relating to obligations of broadband service providers HR 4784 Internet Freedom Act of 2010, provisions relating to obligations of broadband service providers HR 4829 Next Generation 911 Preservation Act, all provisions relating to existing law, regulation or policies that would impact telecommunications network or business operations S 3115 Next Generation 911 Preservation Act, all provisions relating to existing law, regulation or policies that would impact telecommunications network or business operations S 3110 Broadband Service Consumer Protection Act, provisions relating to obligations of broadband service providers S 3427 Pre-Paid Mobile Device Identification Act, provisions relating to wireless telecommunications providers S 3538 National Cyber Infrastructure Protection Act of 2010, provisions relating to cybersecurity and network safety, security and reliability S 3506 Small Business Broadband and Emerging Information Technology Enhancement Act of 2010, provisions relating to broadband service providers HR 5257 Internet Investment, Innovation, and Competition Preservation Act, provisions related to the regulatory classification of broadband internet access services HR 5081 Broadband for First Responders Act of 2010, provisions related to development and design of interoperable broadband public safety networks for the 700 MHz band S 3625 First Responders Protection Act of 2010, provisions related to development and design of interoperable broadband public safety networks for the 700 MHz band S 2881 FCC Commissioners' Technical Resource Enhancement Act, all provisions HR 4809 FCC Commissioners' Technical Resource Enhancement Act, all provisions HR 2195 provisions concerning IP network services HR 5828 Universal Service Reform Act of 2010, provisions related to reformation of existing universal service mechanism S 3742 Data Security and Breach Notification Act of 2010, all provisions related to data security HR 5777 the `BEST PRACTICES Act', provisions relating to customer notice and consent requirements and self regulatory programs S 3756 Public Safety Spectrum and Wireless Innovation Act, provisions relating to efficient spectrum allocation and public safety usage S 3624 Freedom For Consumer Choice Act, issues relating to potential regulation of internet networks S 3872 Cell Phone Bill Shock Act of 2010, provisions relating to consumer usage notification alerts House draft of Cell Phone Bill Shock Act, provisions relating to consumer usage notification alerts S 773 The Cybersecurity Act of 2009, provisions relating to network safety, security and reliability including threat information sharing Issues arising out of the FCC's Open Internet Proceeding and the Framework for Broadband Internet Service Notice of Inquiry, including the scope of appropriate regulatory intervention in the Internet ecosystem and the appropriate regulatory classification of broadband Internet access services Issues related to third party billing Issues related to energy star program for customer premises equipment HR 560 Safe Prisons Communications Act of 2009, provisions relating to wireless telecommunications providers S 251 Safe Prisons Communications Act of 2009, provisions relating to wireless telecommunications providers S 3995 Federal Wi-Net Act, provisions concerning eligible carriers HR 4016 Hazardous Material Transportation Safety Act of 2009, provisions concerning the transportation of lithium cells and batteries on board aircraft
Client expense: $2,910,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Health Issues
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th H.R. 2751, FDA Food Safety Modernization Act (Senate version S. 510) The Breast Cancer Fund supported efforts to pass this legislation because of a possible amendment to ban bisphenol-A, a chemical linked to increased rates of cancer, as well as other significant health problems, from certain food contact materials. The Breast Cancer Fund met with staff from various offices to encourage support for this language and eventual passage of the bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
Client expense: Not reported · Firm income: $40,000
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
2010 · fourth_quarter · Natural Resources
S 1035/ H.R. 3727: To enhance the ability of drinking water utilities in the United States to develop and implement climate change adaptation programs and policies, and for other purposes. HR: 5210: Endocrine Disruptor Screening Enhancement Act; H.R. 4890 and S. 2828 Endocrine Disruption Prevention Act of 2009
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Chemicals/Chemical Industry
H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act of 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 H.R. 5509, Chesapeake Bay Program Reauthorization and Improvement Act S. 1816, Chesapeake Clean Water and Ecosystem Restoration Act S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act of 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities from Disease Clusters Act S. 3834, Representation for Farmers Act
Client expense: $750,621 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE
2010 · fourth_quarter · Chemicals/Chemical Industry
H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) H.R. 5820, Toxic Chemicals Safety Act of 2010 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection
Client expense: $1,530,000 · Firm income: Not reported
2010 · third_quarter · Health Issues
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Health Issues
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Health Issues
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
2010 · third_quarter · Chemicals/Chemical Industry
Toxic Substances Control Act reform (S. 3209 and H.R. 5820); Legislation on endocrine disruptors (H.R. 4190, S. 2828, H.R. 5320, H.R. 5210); Safe Cosmetic Act (H.R. 5786); House investigation into fluids used in hydraulic fracturing ("fracking") process.
Client expense: $290,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2010 · third_quarter · Chemicals/Chemical Industry
H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) H.R. 5820, Toxic Chemicals Safety Act of 2010 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection
Client expense: $2,080,000 · Firm income: Not reported
2010 · third_quarter · Chemicals/Chemical Industry
H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities From Disease Clusters Act S. 3834, Representation for Farmers Act
2010 · third_quarter · Natural Resources
S 1035/ H.R. 3727: To enhance the ability of drinking water utilities in the United States to develop and implement climate change adaptation programs and policies, and for other purposes. HR: 5210: Endocrine Disruptor Screening Enhancement Act; H.R. 4890 and S. 2828 Endocrine Disruption Prevention Act of 2009
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process. S.3209, the Safe Chemicals Act of 2010 (House bill not yet introduced). The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.
2010 · second_quarter · Chemicals/Chemical Industry
H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection
Client expense: $1,790,000 · Firm income: Not reported
2010 · second_quarter · Chemicals/Chemical Industry
Chemical Management/TSCA reform; Endocrine bill/ingredient disclosure. House discussion draft bill and S. 3209, H.R. 4190, S. 2828, H.R. 5320
Client expense: $280,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2010 · second_quarter · Chemicals/Chemical Industry
H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP, POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010
Client expense: $484,916 · Firm income: Not reported
2010 · first_quarter · Health Issues
Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.
2010 · first_quarter · Chemicals/Chemical Industry
H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 519, POPs, LRTAP, POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Atriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010
Client expense: $519,731 · Firm income: Not reported
2010 · first_quarter · Chemicals/Chemical Industry
H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection
Client expense: $2,730,000 · Firm income: Not reported
2009 · fourth_quarter · Health Issues
H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act; Minority Health Disparities (obesity and diabetes); Endocrine Disruptors Issues; H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions H.R.4190, S.2828, Endocrine Disruption Prevention Act of 2009 H.R.4161, Women's Environmental Health and Disease Prevention Act of 2009
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2009 · fourth_quarter · Chemicals/Chemical Industry
H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 S. 519, POPs, LRTAP POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Apporpriations Act, 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009
Client expense: $474,161 · Firm income: Not reported
2009 · fourth_quarter · Chemicals/Chemical Industry
H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2065, Mercury Pollution Reduction Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection
Client expense: $2,120,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of
Client expense: Not reported · Firm income: $40,000
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of
Client expense: $536,591 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), Treasury, Dept of